
Reset all filters
01 1MERCK SHARP & DOHME Ltd
02 1Merck Sharp & Dohme Limited
03 1Merck Sharp & Dohme Ltd
Reset all filters
01 1Ceftolozane Sulfate
02 1Ceftolozane Sulfate; Tazobactam
03 1Several substances refer to content
Reset all filters
01 1Ceftolozano+Tazobactam 1G+0,5G 10 Units Parenteral Use
02 1POWDER FOR CONCENTRATE FOR
03 1Powder to concentrate to the infusion fluid, resolution
Reset all filters
01 1Italy
02 1Norway
03 1Sweden
Reset all filters
01 3Zerbaxa
Regulatory Info :
Registration Country : Sweden
Several substances refer to content
Brand Name : Zerbaxa
Dosage Form : POWDER FOR CONCENTRATE FOR
Dosage Strength : 1 G / 0.5 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Ceftolozane Sulfate; Tazobactam
Brand Name : Zerbaxa
Dosage Form : Ceftolozano+Tazobactam 1G+0,5G 10 Units Parenteral Use
Dosage Strength : 10 bottles groun EV 1 g + 0 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Zerbaxa
Dosage Form : Powder to concentrate to the infusion fluid, resolution
Dosage Strength : 1 g/0.5 g
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway